Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome by Sze, Lisa et al.
University of Wollongong 
Research Online 
Faculty of Health and Behavioural Sciences - 
Papers (Archive) Faculty of Science, Medicine and Health 
January 2011 
Effects of a single dose of exenatide on appetite, gut hormones, and 
glucose homeostasis in adults with Prader-Willi syndrome 
Lisa Sze 
Dept Internal Medicine, St Gallen, Switzerland 
Louise Purtell 
Garvan Inst of Medical Res, St Vincents Hospital 
Arthur Jenkins 
University of Wollongong, ajenkins@uow.edu.au 
Georgina Loughnan 
Royal Prince Alfred Hospital, Sydney-Camperdown 
Ellie Smith 
The Childrens Hospital, Westmead 
See next page for additional authors 
Follow this and additional works at: https://ro.uow.edu.au/hbspapers 
 Part of the Arts and Humanities Commons, Life Sciences Commons, Medicine and Health Sciences 
Commons, and the Social and Behavioral Sciences Commons 
Recommended Citation 
Sze, Lisa; Purtell, Louise; Jenkins, Arthur; Loughnan, Georgina; Smith, Ellie; Herzog, Herbert; Sainsbury, 
Amanda; Steinbeck, Katharine; Campbell, Lesley V.; and Viardot, Alexander: Effects of a single dose of 
exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome 
2011. 
https://ro.uow.edu.au/hbspapers/1071 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
Effects of a single dose of exenatide on appetite, gut hormones, and glucose 
homeostasis in adults with Prader-Willi syndrome 
Abstract 
Context: Prader-Willi syndrome (PWS) is associated with hyperphagia and obesity, without effective 
pharmacological treatment. Exenatide, recently developed for treatment of type 2 diabetes, induces 
appetite suppression and weight loss with common side effects. Objective: The objective of the study 
was to investigate the initial safety and effectiveness of exenatide in adult PWS subjects compared with 
obese controls (OBESE). Design, Setting, Patients, and Intervention: Eight PWS and 11 OBESE patients 
underwent standardized meal studies after a single sc injection of 10 g exenatide or placebo in a single-
blinded, crossover design. Main Outcome Measures: Glucose, insulin, C-peptide, glucagon, peptide YY 
(PYY; total)/PYY (3- 36), glucagon-like peptide-1, and ghrelin (total) were measured fasting and 
postprandially. Appetite and satiety were assessed by visual analog scales. Energy expenditure (EE) was 
measured by indirect calorimetry. Side effects were screened during and for 24 h after the meal. 
Results:PWSand OBESE patients were matched for gender, age, body mass index, and central/total body 
fat. In both groups, exenatide increased satiety and lowered glucose and insulin levels but increased 
insulin secretion rate. Side effects were absent in PWS but common in OBESE patients. During the meal, 
PYY (total) and ghrelin were elevated in PWS patients. Exenatide decreased PYY (total) and glucagon-like 
peptide-1, whereas ghrelin remained unchanged. Energy expenditure was unchanged by exenatide. 
Conclusions: Our pilot study demonstrates that exenatide is well tolerated in PWS patients. It increases 
satiety independently of measured appetite hormones, exerting glucose lowering, and insulinotropic 
effects similarly in PWS and OBESE patients. Larger prospective studies should investigate whether 
chronic exenatide administration will reduce hyperphagia and overweight in PWS patients without side 
effects. 
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